Management and Executive

Founder & CEO

Chief Operating Officer

Meet Jim O’Neill, the longevity enthusiast who is now RFK Jr.’s right-hand man

Longevity investment more than doubled to $8.5bn in 2024

This Pill Promises to Give Your Dog More Years. You Might Not Like What Comes With Them.

Loyal Names Nanette Oddo as Chief Executive Officer, Ushering in a New Era of Growth and Innovation

Senior Director - Program Management

Loyal is a clinical-stage veterinary medicine company focused on developing drugs to enhance the lifespan and health of dogs. The Senior Director, Program Management will lead efforts to bring longevity drug pipelines through FDA approval while supporting the company's growth strategies and ensuring alignment with corporate goals.

Sign up with Google

Sign in with Google